MedPath

The Observational Study of Growth Hormone-secreting Pituitary Tumors

Conditions
Acromegaly
Pituitary Tumor
Registration Number
NCT01368133
Lead Sponsor
Huashan Hospital
Brief Summary

The major purpose of this study is to evaluate the changes of multiple organs in patients with growth hormone-secreting pituitary tumors before and after surgery. Plasma, DNA samples and pituitary tumor tissues will be kept for further analysis.

Detailed Description

Multiple organs or systems will be affected by excessive growth hormones in patients with acromegaly. The major purpose of this study is to evaluate the changes before and after the pituitary surgery.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Clinical diagnosis of acromegaly
  • > 18 years old
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Huashan Hospital

🇨🇳

Shanghai, China

Huashan Hospital
🇨🇳Shanghai, China
Cuiyun Wu
Contact
86-21-52888047
hskyc@fudan.edu.cn
Zhaoyun Zhang
Contact
86-21-52888286
zhaoyunzhang@fudan.edu.cn
Yao Zhao, M.D.
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.